Skip to main content
Fig. 5 | Journal of Nanobiotechnology

Fig. 5

From: CD16 CAR-T cells enhance antitumor activity of CpG ODN-loaded nanoparticle-adjuvanted tumor antigen-derived vaccinevia ADCC approach

Fig. 5

Detection and anti-tumor activity of CL-elicited humoral immune responses. (A) The concentration of Ig antibodies in various serum samples. (B) Cytotoxic effects of serum samples on B16F10 tumor cells. (C) Cytotoxic effects of serum samples on B16F10 and 4T1 tumor cells. (D) Anti-tumor growth activity of various serum samples. The data were presented as means ± s. d. Statistical significance was calculated by one-way analysis of variance (ANOVA). (n = 5), ***p < 0.001

Back to article page